Cargando…

Anaplastic Thyroid Cancer Presenting With Brain Metastasis: 17-year Progression Free Survival

Anaplastic Thyroid Cancer is the most aggressive thyroid cancer with a median survival of just five months. Long term survival has been reported in locally aggressive cases but has yet to be reported in metastatic disease. This is a report of a 34-year-old male who presented with symptoms of dizzine...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Kathryn Kay, Lapkus, Morta, Luehmann, Natalie, Nagar, Sapna, Czako, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089615/
http://dx.doi.org/10.1210/jendso/bvab048.1802
_version_ 1783687081277521920
author Howard, Kathryn Kay
Lapkus, Morta
Luehmann, Natalie
Nagar, Sapna
Czako, Peter
author_facet Howard, Kathryn Kay
Lapkus, Morta
Luehmann, Natalie
Nagar, Sapna
Czako, Peter
author_sort Howard, Kathryn Kay
collection PubMed
description Anaplastic Thyroid Cancer is the most aggressive thyroid cancer with a median survival of just five months. Long term survival has been reported in locally aggressive cases but has yet to be reported in metastatic disease. This is a report of a 34-year-old male who presented with symptoms of dizziness, confusion, intermittent headaches, and erratic behavior for two weeks found to have metastatic anaplastic thyroid cancer. CT of the head revealed a 1 cm ring enhancing lesion and he was taken to the operating room for a left parietal craniotomy with mass removal. Initial pathology suggested papillary thyroid origin. His neck exam revealed a palpable 3 cm mass in the right thyroid lobe and he subsequently underwent total thyroidectomy. Final pathology revealed anaplastic carcinoma identical to the brain lesion. Post-operatively, he underwent 15 cycles of whole brain radiation therapy. Two additional brain lesions were identified after thyroidectomy and a third was identified after whole brain radiation. He underwent stereotactic radiosurgery of these three lesions less than two months after thyroidectomy. The patient went on to receive modified mantle field irradiation to the neck, thyroid bed, and the upper mediastinum and chemotherapy with doxorubicin for 6-8 weeks and temozolomide for 2 years. Radioactive iodine treatment was not administered. The patient has currently survived 17 years and his persistent, but stable, brain lesions are being followed with serial imaging. He remains clinically and neurologically asymptomatic. This is the first case presenting with long-term survival in a patient with metastatic anaplastic thyroid carcinoma.
format Online
Article
Text
id pubmed-8089615
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-80896152021-05-06 Anaplastic Thyroid Cancer Presenting With Brain Metastasis: 17-year Progression Free Survival Howard, Kathryn Kay Lapkus, Morta Luehmann, Natalie Nagar, Sapna Czako, Peter J Endocr Soc Thyroid Anaplastic Thyroid Cancer is the most aggressive thyroid cancer with a median survival of just five months. Long term survival has been reported in locally aggressive cases but has yet to be reported in metastatic disease. This is a report of a 34-year-old male who presented with symptoms of dizziness, confusion, intermittent headaches, and erratic behavior for two weeks found to have metastatic anaplastic thyroid cancer. CT of the head revealed a 1 cm ring enhancing lesion and he was taken to the operating room for a left parietal craniotomy with mass removal. Initial pathology suggested papillary thyroid origin. His neck exam revealed a palpable 3 cm mass in the right thyroid lobe and he subsequently underwent total thyroidectomy. Final pathology revealed anaplastic carcinoma identical to the brain lesion. Post-operatively, he underwent 15 cycles of whole brain radiation therapy. Two additional brain lesions were identified after thyroidectomy and a third was identified after whole brain radiation. He underwent stereotactic radiosurgery of these three lesions less than two months after thyroidectomy. The patient went on to receive modified mantle field irradiation to the neck, thyroid bed, and the upper mediastinum and chemotherapy with doxorubicin for 6-8 weeks and temozolomide for 2 years. Radioactive iodine treatment was not administered. The patient has currently survived 17 years and his persistent, but stable, brain lesions are being followed with serial imaging. He remains clinically and neurologically asymptomatic. This is the first case presenting with long-term survival in a patient with metastatic anaplastic thyroid carcinoma. Oxford University Press 2021-05-03 /pmc/articles/PMC8089615/ http://dx.doi.org/10.1210/jendso/bvab048.1802 Text en © The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Thyroid
Howard, Kathryn Kay
Lapkus, Morta
Luehmann, Natalie
Nagar, Sapna
Czako, Peter
Anaplastic Thyroid Cancer Presenting With Brain Metastasis: 17-year Progression Free Survival
title Anaplastic Thyroid Cancer Presenting With Brain Metastasis: 17-year Progression Free Survival
title_full Anaplastic Thyroid Cancer Presenting With Brain Metastasis: 17-year Progression Free Survival
title_fullStr Anaplastic Thyroid Cancer Presenting With Brain Metastasis: 17-year Progression Free Survival
title_full_unstemmed Anaplastic Thyroid Cancer Presenting With Brain Metastasis: 17-year Progression Free Survival
title_short Anaplastic Thyroid Cancer Presenting With Brain Metastasis: 17-year Progression Free Survival
title_sort anaplastic thyroid cancer presenting with brain metastasis: 17-year progression free survival
topic Thyroid
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089615/
http://dx.doi.org/10.1210/jendso/bvab048.1802
work_keys_str_mv AT howardkathrynkay anaplasticthyroidcancerpresentingwithbrainmetastasis17yearprogressionfreesurvival
AT lapkusmorta anaplasticthyroidcancerpresentingwithbrainmetastasis17yearprogressionfreesurvival
AT luehmannnatalie anaplasticthyroidcancerpresentingwithbrainmetastasis17yearprogressionfreesurvival
AT nagarsapna anaplasticthyroidcancerpresentingwithbrainmetastasis17yearprogressionfreesurvival
AT czakopeter anaplasticthyroidcancerpresentingwithbrainmetastasis17yearprogressionfreesurvival